In Vitro Profiling of the Synthetic RNA Polymerase Inhibitor MMV688845 against Mycobacterium abscessus
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In Vitro
Profiling of the Synthetic RNA Polymerase Inhibitor MMV688845 against Mycobacterium abscessus
Authors
Keywords
-
Journal
Microbiology Spectrum
Volume 10, Issue 6, Pages -
Publisher
American Society for Microbiology
Online
2022-11-15
DOI
10.1128/spectrum.02760-22
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Racemization-free synthesis of Nα-2-thiophenoyl-phenylalanine-2-morpholinoanilide enantiomers and their antimycobacterial activity
- (2021) Lea Mann et al. AMINO ACIDS
- Blocking Bacterial Naphthohydroquinone Oxidation and ADP-Ribosylation Improves Activity of Rifamycins against Mycobacterium abscessus
- (2021) Uday S. Ganapathy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Accurate prediction of protein structures and interactions using a three-track neural network
- (2021) Minkyung Baek et al. SCIENCE
- Mycobacterium abscessus
- (2021) Yves-Marie Boudehen et al. TRENDS IN MICROBIOLOGY
- Nontuberculous Mycobacterial Infections – a neglected and emerging problem
- (2020) Imran Ahmed et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus
- (2020) Matt D. Johansen et al. NATURE REVIEWS MICROBIOLOGY
- Extreme Drug Tolerance of Mycobacterium abscessus “Persisters”
- (2020) Yee-Kuen Yam et al. Frontiers in Microbiology
- Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline: Executive Summary
- (2020) Charles L Daley et al. CLINICAL INFECTIOUS DISEASES
- The complexities and challenges of preventing and treating nontuberculous mycobacterial diseases
- (2019) Susan L. Baldwin et al. PLoS Neglected Tropical Diseases
- Gut Microbiota Metabolite Indole Propionic Acid Targets Tryptophan Biosynthesis in Mycobacterium tuberculosis
- (2019) Dereje Abate Negatu et al. mBio
- Repositioning rifamycins for Mycobacterium abscessus lung disease
- (2019) Uday S. Ganapathy et al. Expert Opinion on Drug Discovery
- Rifabutin is active against Mycobacterium abscessus in mice
- (2019) Thomas Dick et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- THP-1 and Dictyostelium Infection Models for Screening and Characterization of Anti-Mycobacterium abscessus Hit Compounds
- (2019) Adrian Richter et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dissecting erm(41)-Mediated Macrolide-Inducible Resistance in Mycobacterium abscessus
- (2019) Matthias Richard et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rifabutin acts in synergy and is bactericidal with frontline Mycobacterium abscessus antibiotics clarithromycin and tigecycline, suggesting a potent treatment combination
- (2018) Mark Pryjma et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Screening of preselected libraries targeting Mycobacterium abscessus for drug discovery
- (2018) Adrian Richter et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pathogen Box screening for hit identification against Mycobacterium abscessus
- (2018) Jinsun Jeong et al. PLoS One
- Treatment of Mycobacterium abscessus Complex
- (2018) Kevin Winthrop et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Amphiphilic Indole Derivatives as Antimycobacterial Agents: Structure–Activity Relationships and Membrane Targeting Properties
- (2017) Tianming Yang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structural Basis of Mycobacterium tuberculosis Transcription and Transcription Inhibition
- (2017) Wei Lin et al. MOLECULAR CELL
- Screening of TB Actives for Activity against Nontuberculous Mycobacteria Delivers High Hit Rates
- (2017) Jian Liang Low et al. Frontiers in Microbiology
- Development of an Intracellular Screen for New Compounds Able To Inhibit Mycobacterium tuberculosis Growth in Human Macrophages
- (2015) Flavia Sorrentino et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Erm(41)-dependent inducible resistance to azithromycin and clarithromycin in clinical isolates of Mycobacterium abscessus
- (2014) F. P. Maurer et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Fueling Open-Source Drug Discovery: 177 Small-Molecule Leads against Tuberculosis
- (2013) Lluís Ballell et al. ChemMedChem
- Evaluation of the pathogenesis and treatment of Mycobacterium marinum infection in zebrafish
- (2013) Kevin Takaki et al. Nature Protocols
- A Dual Read-Out Assay to Evaluate the Potency of Compounds Active against Mycobacterium tuberculosis
- (2013) Juliane Ollinger et al. PLoS One
- The Genome Sequence of ‘Mycobacterium massiliense’ Strain CIP 108297 Suggests the Independent Taxonomic Status of the Mycobacterium abscessus Complex at the Subspecies Level
- (2013) Yong-Joon Cho et al. PLoS One
- Nontuberculous mycobacterial (NTM) lung disease: The top ten essentials
- (2013) Timothy R. Aksamit et al. RESPIRATORY MEDICINE
- Draft Genome Sequence of Mycobacterium abscessus subsp. bolletii BDT
- (2012) G.-E. Choi et al. JOURNAL OF BACTERIOLOGY
- Assessment of Clarithromycin Susceptibility in Strains Belonging to theMycobacterium abscessusGroup byerm(41) andrrlSequencing
- (2010) Sylvaine Bastian et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Non Mycobacterial Virulence Genes in the Genome of the Emerging Pathogen Mycobacterium abscessus
- (2009) Fabienne Ripoll et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now